The global market of Monocalcium Phosphate (Monohydrate) has faced a correction in May xxxx which was marked by sharp price reductions across major trading hubs. This downturn was a result of strategic pricing decisions by exporters, subdued procurement interest from downstream sectors and persistent inventory accumulation at the buyer鈥檚 end. The market environment of Monocalcium Phosphate has remained heavily oversupplied while procurement strategies from key pharmaceutical, nutraceutical and medical industries was conservative. The situation was catalysed with easing production costs that resulted in a steep fall in prices throughout the month.
The industry participants of Monocalcium Phosphate have attributed the downturn to a confluence of factors. A critical driver was the consistent softening of feedstock input costs, especially phosphoric acid which allowed producers to lower their production costs and extend more competitive offers to maintain market presence. The downstream sectors, primarily...
